Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 study

A3921147 Study Investigators

Research output: Contribution to journalArticlepeer-review

122 Scopus citations

Fingerprint

Dive into the research topics of 'Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences